Cytogenetic Nomenclature and Reporting.
暂无分享,去创建一个
Katrina Rack | Annet Simons | Marian Stevens-Kroef | R. Hastings | A. Simons | M. Stevens-Kroef | Rosalind J Hastings | K. Rack
[1] M. Salido,et al. Guidelines for cytogenetic investigations in tumours , 2015, European Journal of Human Genetics.
[2] Borut Peterlin,et al. Recommendations for reporting results of diagnostic genetic testing (biochemical, cytogenetic and molecular genetic) , 2013, European Journal of Human Genetics.
[3] Birgit Sikkema-Raddatz,et al. Genome‐wide arrays in routine diagnostics of hematological malignancies , 2012, Human mutation.
[4] E. van den Berg,et al. Guidelines for genomic array analysis in acquired haematological neoplastic disorders , 2016, Genes, chromosomes & cancer.
[5] R. Goswami,et al. Isolated +15 in bone marrow: disease-associated or a benign finding? , 2015, Leukemia research.
[6] J. McGowan-Jordan,et al. Canadian College of Medical Geneticists guidelines for the indications, analysis, and reporting of cancer specimens. , 2011, Current oncology.
[7] P. Patsalis,et al. Cytogenetic Guidelines and Quality Assurance: a common European framework for quality assessment for constitutional and acquired cytogenetic investigations , 2007, European Journal of Human Genetics.
[8] D. Steensma,et al. Isolated trisomy 15: a clonal chromosome abnormality in bone marrow with doubtful hematologic significance. , 2008, American journal of clinical pathology.
[9] F. Mitelman,et al. Cancer cytogenetics: Chromosomal and Molecular Genetic Aberrations of Tumor Cells , 2015 .